Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Special Correspondent

Siddha, Ayurveda drugs to the fore ahead of ‘third wave’of COVID-19

File Photo | Rashtriya Ayurved Vidyapeeth, New Delhi, an autonomous organisation under the Union Ministry of AYUSH, conducted an awareness programme on August 31. (Source: The Hindu)

Ahead of the predicted third wave of COVID-19 that is feared to rear its head by September, preventive medicines and immunity boosters from the Ayurvedic and Siddha medicinal streams are back in the reckoning. This time, they are coming up under the banner of ‘Azadi ka Amrit Mahotsav’, commemorating the 75th year of Indian Independence.

Rashtriya Ayurved Vidyapeeth, New Delhi, an autonomous organisation under the Union Ministry of AYUSH, conducted an awareness programme on Tuesday on ‘Possible COVID-19 third wave and the role of Ayurveda’, where Ayurvedic physician ‘Guru’ M. Bhaskar Rao spoke on the precautions to be taken to stay physically and mentally strong to tackle the third wave. Dr. Bhaskar Rao, who retired as the vice-principal of Sri Venkateswara Ayurvedic College, has been designated as ‘Guru’ by the Vidyapeeth that functions under the ‘Guru-Sishya parampara’. Narendra Yogi and Lakhan Trivedi, designated as Dr. Rao’s disciples, distributed Chyawanprash Lehya, Ashvagandhadi Lehya and Immunex DS, a herboceutical tablet, and explained their role in strengthening immunity.

Similarly, Tirupati-based Siddha Clinical Research Unit, also functioning under the AYUSH Ministry, launched a week-long programme to distribute ‘Amukkara Chooranam’. Intending to create awareness on lifestyle modifications required to tame the virus, the research unit in-charge K. Samraj distributed leaflets to the public.

Siddha Ethics Committee member P.V. Balaji Deekshitulu gave away the Chooranam containing ashwagandha, pepper, dry ginger, clove, jaggery and cinnamon, collectively known to improve strength and develop acquired immunity against COVID-19 infection. Dr. Samraj said the medicine would be distributed free of cost, especially to the geriatric population considered more vulnerable to the virus.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.